Page last updated: 2024-09-02

ecteinascidin 743 and Chordoma

ecteinascidin 743 has been researched along with Chordoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Constantinidou, A; Jones, RL; Loggers, E; Pollack, S; Rodler, E1
Choy, E; Duan, Z; Hornicek, FJ; Iafrate, J; Mankin, H; Nielsen, GP; Rosenberg, A; Schwab, JH; Wood, KB; Xavier, RJ; Yang, C1

Reviews

1 review(s) available for ecteinascidin 743 and Chordoma

ArticleYear
The evolution of systemic therapy in sarcoma.
    Expert review of anticancer therapy, 2013, Volume: 13, Issue:2

    Topics: Angiogenesis Inhibitors; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chordoma; Deoxycytidine; Dermatofibrosarcoma; Dioxoles; Docetaxel; Drug Resistance, Neoplasm; Gemcitabine; Hemangiosarcoma; Humans; Osteosarcoma; Proteasome Inhibitors; Receptor, IGF Type 1; Sarcoma; Soft Tissue Neoplasms; Taxoids; Tetrahydroisoquinolines; TOR Serine-Threonine Kinases; Trabectedin

2013

Other Studies

1 other study(ies) available for ecteinascidin 743 and Chordoma

ArticleYear
Characterization and analysis of human chordoma cell lines.
    Spine, 2010, Jun-01, Volume: 35, Issue:13

    Topics: Antineoplastic Agents; Biomarkers, Tumor; Blotting, Western; Cell Culture Techniques; Cell Hypoxia; Cell Line, Tumor; Cell Proliferation; Chordoma; Cisplatin; Collagen; Dioxoles; Doxorubicin; Drug Screening Assays, Antitumor; Fluorescent Antibody Technique; Glucose; Humans; Keratins; Tetrahydroisoquinolines; Trabectedin; Vimentin

2010